• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Person › Details

David Dible (Citigate Dewe Rogerson Ltd.)

Dible, David (Huntsworth 201506 Senior Director Life Sciences at Citigate Dewe Rogerson London)

 

	Organisation	Citigate Dewe Rogerson Ltd.
	Group	Huntsworth (Group)
	Product	public relations / investor relations / marcom (services)

Record changed: 2021-03-19

Advertisement

More documents for David Dible

• [1] Transgene S.A.. (6/14/19). "Press Release: Transgene Launches a Rights Issue for an Amount of up to €50 Million [This document must not be distributed, directly or indirectly, in the United States of America, Australia, Canada or Japan]". Strasbourg....
• [2] Oxurion N.V.. (9/10/18). "Press Release: Oxurion NV Announces New Euronext Brussels Stock Ticker “OXUR” and Launch of New Website". Leuven....
• [3] Transgene S.A.. (8/20/18). "Press Release: Transgene Completes the Sale of the Greater China Rights of TG6002 and TG1050 to Tasly Biopharmaceuticals for $48 Million in Newly-Issued Shares". Strasbourg....
• [4] Heptares Therapeutics Ltd.. (1/10/18). "Press Release: Sosei Subsidiary, Heptares, Enters Drug R&D Collaboration with Imperial College London Focused on Multiple GPCR Disease Target Opportunities in the Gastro-intestinal Tract". Tokyo & London....
• [5] Advicenne S.A.. (1/5/18). "Press Release: Partial Exercise of Over-allotment Option. Capital Increase of around €27.8 Million [NOT FOR USA, AUSTRALIA, CANADA OR JAPAN]". Nîmes....
• [6] ThromboGenics N.V.. (12/8/17). "Press Release: Patient Enrolment in Phase II CIRCLE Study Evaluating THR-409 (ocriplasmin) for Non-Proliferative Diabetic Retinopathy (NPDR) Discontinued Due to Slow Recruitment Rate". Leuven....
• [7] Advicenne S.A.. (12/5/17). "Press Release: Advicenne Raises €27 Million in Successful IPO on Euronext Paris [THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISSEMINATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY TO THE USA, AUSTRALIA, CANADA OR JAPAN]". Nîmes....
• [8] Owlstone Medical Ltd.. (11/27/17). "Press Release: Owlstone Medical’s Breath Biopsy Platform Integrated into GSK’s Phase II Respiratory Disease Clinical Trial". Cambridge....
• [9] Advicenne S.A.. (11/21/17). "Press Release: Advicenne Launches IPO on Euronext's Regulated Market in Paris [NOT FOR USA, AUSTRALIA, CANADA OR JAPAN]". Nîmes....
• [10] ThromboGenics N.V.. (10/20/17). "Press Release: ThromboGenics Business Update – Q3 2017". Leuven....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.